Literature DB >> 16555021

Expression of prostate-specific membrane antigen in normal and malignant human tissues.

Yoshihisa Kinoshita1, Katsuyuki Kuratsukuri, Steve Landas, Katsumi Imaida, Peter M Rovito, Ching Y Wang, Gabriel P Haas.   

Abstract

BACKGROUND: Prostate-specific membrane antigen (PSMA) is upregulated in androgen-dependent prostate carcinoma and it has been targeted for immunotherapy and diagnosis of this cancer. However, this protein is also expressed in other tissues. The objective of this study is to investigate its expression in normal and malignant human tissues.
METHODS: Using monoclonal antibodies 24.4E6 (specific for residues 638-657) and 7E11.C5 (specific for the transmembrane domain of PSMA), immunohistochemical detection of PSMA was performed in surgical specimens.
RESULTS: Prostate-specific membrane antigen was detected in the epithelium of prostate, urinary bladder, proximal tubules of kidney, liver, esophagus, stomach, small intestine, colon, breast, fallopian tubes and testicular seminiferous tubules, hippocampal neurons and astrocytes, ependyma, cortex and medulla of the adrenal gland, and ovary stroma. It was also detected in neoplasms of the prostate, kidney, urinary bladder, stomach, small intestine, colon, lung, adrenal gland, and testis. It was not detected in normal seminal vesicles or the lung.
CONCLUSIONS: These findings demonstrate that PSMA is widely distributed in normal tissues, and, depending on the tumors, its expression is up- or down-regulated, or unchanged. The broad distribution of PSMA may make it suitable for the diagnosis and therapy of a wide variety of tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16555021     DOI: 10.1007/s00268-005-0544-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.282


  36 in total

1.  Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization.

Authors:  M Kawakami; J Nakayama
Journal:  Cancer Res       Date:  1997-06-15       Impact factor: 12.701

2.  Expression of prostate-specific membrane antigen in transitional cell carcinoma of the bladder: prognostic value?

Authors:  J L Gala; S Loric; Y Guiot; S R Denmeade; A Gady; F Brasseur; M Heusterspreute; P Eschwège; P De Nayer; P Van Cangh; B Tombal
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

3.  Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase.

Authors:  D J Bacich; J T Pinto; W P Tong; W D Heston
Journal:  Mamm Genome       Date:  2001-02       Impact factor: 2.957

4.  A prostate-specific membrane antigen-targeted monoclonal antibody-chemotherapeutic conjugate designed for the treatment of prostate cancer.

Authors:  Michael D Henry; Shenghua Wen; Matthew D Silva; Sudeep Chandra; Mark Milton; Peter J Worland
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

5.  A dual-monoclonal sandwich assay for prostate-specific membrane antigen: levels in tissues, seminal fluid and urine.

Authors:  R L Sokoloff; K C Norton; C L Gasior; K M Marker; L S Grauer
Journal:  Prostate       Date:  2000-05-01       Impact factor: 4.104

6.  Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell line.

Authors:  L S Grauer; K D Lawler; J L Marignac; A Kumar; A S Goel; R L Wolfert
Journal:  Cancer Res       Date:  1998-11-01       Impact factor: 12.701

7.  Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.

Authors:  Thomas D Schmittgen; Sabine Teske; Robert L Vessella; Lawrence D True; Brian A Zakrajsek
Journal:  Int J Cancer       Date:  2003-11-01       Impact factor: 7.396

8.  Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase).

Authors:  R Luthi-Carter; A K Barczak; H Speno; J T Coyle
Journal:  J Pharmacol Exp Ther       Date:  1998-08       Impact factor: 4.030

Review 9.  Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.

Authors:  Arundhati Ghosh; Warren D W Heston
Journal:  J Cell Biochem       Date:  2004-02-15       Impact factor: 4.429

10.  Role of glutamate receptors in the development and maintenance of bladder overactivity after cerebral infarction in the rat.

Authors:  Osamu Yokoyama; Hiroaki Mizuno; Kazuto Komatsu; Hironobu Akino; Kazuya Tanase; Mikio Namiki
Journal:  J Urol       Date:  2004-04       Impact factor: 7.450

View more
  79 in total

1.  NKX3.1 and PSMA are sensitive diagnostic markers for prostatic carcinoma in bone metastasis after decalcification of specimens.

Authors:  Hongying Huang; Sergei R Guma; Jonathan Melamed; Ming Zhou; Peng Lee; Fang-Ming Deng
Journal:  Am J Clin Exp Urol       Date:  2018-10-20

2.  Manipulation of Cell-Type Selective Antibody Internalization by a Guide-Effector Bispecific Design.

Authors:  Nam-Kyung Lee; Yang Su; Scott Bidlingmaier; Bin Liu
Journal:  Mol Cancer Ther       Date:  2019-04-08       Impact factor: 6.261

3.  PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responses.

Authors:  Victor D Fedorov; Maria Themeli; Michel Sadelain
Journal:  Sci Transl Med       Date:  2013-12-11       Impact factor: 17.956

Review 4.  PET imaging in renal cancer.

Authors:  Liza Lindenberg; Esther Mena; Peter L Choyke; Kirsten Bouchelouche
Journal:  Curr Opin Oncol       Date:  2019-05       Impact factor: 3.645

Review 5.  Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies.

Authors:  Emma E van der Toom; Haley D Axelrod; Jean J de la Rosette; Theo M de Reijke; Kenneth J Pienta; Kenneth C Valkenburg
Journal:  Nat Rev Urol       Date:  2019-01       Impact factor: 14.432

6.  Pitfalls in Ga-68-PSMA-PET/CT: incidental finding of parathyroid adenoma.

Authors:  Christian H Pfob; Ilham Karimov; Moritz Jesinghaus; Alexander Novotny; Wolfgang A Weber; Matthias Eiber; Benedikt Feuerecker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-12-19       Impact factor: 9.236

7.  Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases.

Authors:  Mariz Kasoha; Clara Unger; Erich-Franz Solomayer; Rainer M Bohle; Claudia Zaharia; Fadi Khreich; Stefan Wagenpfeil; Ingolf Juhasz-Böss
Journal:  Clin Exp Metastasis       Date:  2018-02-10       Impact factor: 5.150

8.  Topology of NGEP, a prostate-specific cell:cell junction protein widely expressed in many cancers of different grade level.

Authors:  Sudipto Das; Yoonsoo Hahn; Dawn A Walker; Satoshi Nagata; Mark C Willingham; Donna M Peehl; Tapan K Bera; Byungkook Lee; Ira Pastan
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

9.  Free/Total Serum Prostate-Specific Antigen Ratio in Women with Colorectal Cancer Has Prognostic Significance.

Authors:  Nüvit Duraker; Zeynep Civelek Çaynak; Didem Can Trabulus
Journal:  J Gastrointest Cancer       Date:  2017-03

10.  Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen.

Authors:  Ying Chen; Mrudula Pullambhatla; Sangeeta R Banerjee; Youngjoo Byun; Marigo Stathis; Camilo Rojas; Barbara S Slusher; Ronnie C Mease; Martin G Pomper
Journal:  Bioconjug Chem       Date:  2012-12-04       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.